Atmo Biosciences’ revolutionary gas-sensing capsule, supported by Breakthrough Victoria, transforms gastrointestinal diagnosis with real-time gut data, providing a non-invasive and patient-friendly approach to FGID diagnosis.
Five Australian digital health companies secure $3.75M in funding to scale products nationally and internationally.
Australian Event Achieves Sustainability Milestones with Circular Economy Councils Fund, Diverts 3,500kg of Waste from Landfill.
CEFC to reduce construction and demolition waste for Brisbane Olympics.
Funding is available to support the development of innovative health technologies that can improve health outcomes.
Funding is available to support small businesses, not-for-profit and community sport organisations directly affected by the Victorian floods.
Funding is available to help medical researchers to analyse and share existing data infrastructure in new ways.
Funding is available to develop and commercialise its biomedical discoveries.
Funding is available to support SMEs and scaleups to commercialise products that address the economic impacts of COVID-19.
9 recipients received $6.7 million to support clinical trials for the diabetes and cardiovascular diseases.
